BehaveNet^®
Clinical Capsule™

Join Our Mailing List

Follow updates to BehaveNet with Twitter

drug:

paroxetine

Clinical class	antidepressant
Action	Selective serotonin reuptake inhibitor
Chemical class	phenylpiperidine
CSA schedule	none
DEA number	none
Routes of administration	oral
Associated with (substance-related)	disorders: none
Availability	prescription

MEDLINEplus^® Drug Information

U.S. Preparations:

Paxil^® (GlaxoSmithKline) FDA approved for treatment of:
12.29.1992 Depression
5.7.1996 Obsessive Compulsive Disorder
5.7.1996 Panic Disorder
5.11.1999 Social Anxiety Disorder
4.13.2001 Generalized Anxiety Disorder
12.14.2001 Posttraumatic Stress Disorder
US Prescribing Information

Dose:	10 mg.		20 mg.		30 mg.		40 mg.
Color:	yellow		pink		blue		green
Shape:	oval		oval		oval		oval
Type:	film-coated scored tablet		film-coated scored tablet		film-coated tablet		film-coated tablet
Imprint:	"Paxil"	10	"Paxil"	20	"Paxil"	30	"Paxil"	40

Paxil CR^® (GlaxoSmithKline) FDA approved for treatment of:
2.16.1999 Depression
2.21.2002 Panic Disorder
8.28.2003 premenstrual dysphoric disorder
10.16.2003 Social Anxiety Disorder
US Prescribing Information

Dose:	12.5 mg.		25 mg.		37.5 mg.
Color:	yellow		pink		blue
Shape:	round		round		round
Type:	enteric film-coated tablet		enteric film-coated tablet		enteric film-coated tablet
Imprint:	"Paxil CR"	12.5	"Paxil CR"	25	"Paxil CR"	37.5

Pexeva™ (Synthon) FDA approved for treatment of:
7.3.2003 Major Depressive Disorder
7.3.2003 Obsessive Compulsive Disorder
7.3.2003 Panic Disorder
12.9.2006 Generalized Anxiety Disorder
US Prescribing Information

Preparations Outside U.S.:

Aropax, Deroxat, Eutimil, Frosinor, Frosnor, Motivan, Sereupin, Seroxal, Seroxat, Tagonis

Stephen Stahl's Clinical Pearls* (Consult your physician before making any change in your treatment.)

Potent 2D6 inhibitor.
NOT linear dosing (i.e., 20, 30, 40 mg).
Inhibits own metabolism.
Least selective over acetylcholine, thus some mild anticholinergic side effects.
FDA label in USA for depression, panic and OCD.
Washout can be too rapid with withdrawal effects, especially movement disorders, akathisia, dystonia, restlessness, and GI symptoms plus dizziness.
Generally well tolerated in panic.
Consider for mixed anxiety depression.
Consider avoiding in patients with hypersomnia, retardation, insomniacs, or those who wish to avoid sexual dysfunction.

Books and Other Media:
Follow the hypertext link to purchase items.

*Reprinted with permission from: Stahl, Stephen M Psychopharmacology of Antidepressants Paperback 1997 Martin Dunitz, Ltd & Blackwell Science You cannot fully appreciate this book until you have seen the extraordinary illustrations of every aspect of this area of psychopharmacology and neurochemistry. Loaded with practical clinical "pearls."

BehaveNet® Clinical Capsule™